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1. Introduction 
 
1.1. Embryonic development of the chick 
 
The ovum consists of the yellow yolk plus a small yolk-free area called the 
blastoderm (blastodisc, germinal disc). The nucleus of the ovum is in the blastodisc. 
The blastodisc appears as a small whitish area on the upper surface of the yolk.  
Albumen is added to the ovum as it moves down the hen's oviduct. A viscous 
albumen is first added and is twisted into a pair of strands as the ovum passes down 
the oviduct. Each strand of viscous albumen is called a chalaza. A watery albumen is 
added to the ovum further down the oviduct. Eventually 2 shell membranes and a 
calcareous shell are added to form the complete "egg". (Note: The yolk serves as a 
food source, while the albumen serves as a source of protein and water).  
Because of the large amount of yolk present in the hen's egg, cleavage, 
morphogenesis and differentiation are confined to the blastoderm. Initially the 
blastoderm becomes several cell layers thick and a cavity, called the subgerminal 
cavity, is formed under this layer. This stage of the embryo is comparable to the 
starfish morula. As cleavage continues and more cells are formed there is eventually 
a splitting of the blastoderm to form 2 layers, a dorsal epiblast (ectoderm) and ventral 
hypoblast (endoderm). This embryo stage corresponds to the starfish blastula and 
the cavity separating these 2 layers is called the blastocoel. Development to this 
stage takes place while the egg is still in the oviduct of the hen. Further development 
will takes place only if the egg is brooded by the hen or placed in an incubator at 37 
degrees C.  
Gastrulation occurs by a process of involution. Involution is the curling inward and 
ingrowth of a group of cells. Cells of the blastoderm surface migrate posteriorly and 
medially and involute (turn in) along a line called the primitive streak. These involuted 
cells will form the mesoderm germ layer. As gastrulation progresses, the anterior end 
of the streak moves posteriorly, so the anterior region of the embryo is formed first. 
The primitive streak is functionally the same as the blastopore of the starfish gastrula.  
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The 3 germ layers (ectoderm, endoderm and mesoderm) are present following 
gastrulation by involution. The coelom results from a splitting of the lateral 
mesoderm. The involuted cells form the notochord anterior to the primitive streak and 
the lateral mesoderm (somites) laterally. Somitogenesis starts at 23-26 hours and 
ends 3.5 days after fertilization. At the same time as the first somite is built, the 
central ectoderm folds down to build the neural fold and later the neural tube. At the 3 
somite stage the coelom is built. At the 4 somite stage the first blood islands appear. 
With 7 somites (29-33 hours after fertilization) the primary optic vesicles are formed 
and with 8-9 somites the anterior amniotic fold is formed. 33-38 hours after 
fertilization, at the 10 somites stage, the anterior neural tube forms 3 primary brain 
vesicles. At the 13 somites stage 5 neuromeres of the hindbrain and at the 16 
somites stage the telencephalon are formed. At the 19 somites stage the 
arterioventricular canal appears. At the 21-22 somites stage the tail bud is formed. 
With 22 somites the trunk flexure and the visceral arches 1 and 2 are formed. At the 
23 somites stage the premandibula and the head cavities are formed. Then the 
visceral arch 3 is formed. After that, when the embryo has 28 somites, the wing buds 
appear and, with 32 somites, the leg buds. At the 40 somites stage the maxillary 
process grows and at the 43 somite stage the eye pigment is produced. With 44 
somites the visceral arch 4 is formed and the somites extend to tip of tail. 3.5 days 
after fertilization, somitogenesis is complete. Four days after fertilisation, the dorsal 
contour from hindbrain to tail becomes a curved line. Half a day later the toe plate is 
formed. At day 5 the elbow and knee joints are formed, as well as the first 3 toes. 
Half day later the beak appears. At day 6 the embryo already possesses 3 digits and 
four toes on its limbs. Then the rudiment of the 5th toe is formed. At the following two 
days the mandible reaches the beak and webs are built between the digits along the 
wings. At day 9 after fertilisation the falanges of the toes are formed and the 
primordium comb is formed. During the following 10 days the embryo grows and the 
extra-embryonic blood vessels are reduced. 20-21 days after fertilization the chick 
hatches. 
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1.2.  The mid/hindbrain boundary is an autonomic 
signalling centre for brain differentiation. 
 
Several molecular mechanisms control the patterning and differentiation of the neural 
tube along the anteroposterior axis. In the hindbrain, segmentation and rhombomere-
specific expression of members of the Hox gene families are essential regulatory 
elements. Segment specific expression of the different Hox genes is responsible for 
the differentiation of the embryo along the anterioposterior axis [8]. 
However, early transplantation experiments in chicken showed that there is an 
organizing centre in the mid/hindbrain boundary. [9] Cells of one region of the 
embryo transplanted to other regions in general regulate their development in 
response to the new environment. In contrast, if cells of the mid/hindbrain junction 
are included in the transplants, the tissue maintains its developmental fate and 
furthermore induces the surrounding cells to form mesencephalic or metencephalic 
structures. Likewise, fore- or hindbrain cells transplanted near the mid/hindbrain 
boundary change their fate to form mesencephalic structures. 
This inducing capacity of the mid/hindbrain region makes it highly interesting for the 
investigation of the mechanisms of cell differentiation and the genes that induce it.  
 
1.2.1. Genes expressed in the mid/hindbrain boundary 
 
Molecules involved in neuroaxial patterning include the homeodomain transcription 
factors Otx2, Gbx2, En1 and En2, the paired-box containing transcription factors 
Pax2, Pax5 and Pax8 and the secreted factors Wnt1 and Fgf8. 
Among the earliest genes expressed in the nervous system are Otx2 and Gbx2 [11]. 
Otx2 is expressed from the anterior tip of the neural plate to the presumptive 
mid/hindbrain boundary [12]. In contrast, Gbx2 is expressed in the presumptive 
hindbrain with an anterior boundary in the future isthmus region [13]. The border that 
divides the Otx2 expression region from the Gbx2 expression region determines the 
position of the mid/hindbrain boundary [14]. 
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When somitogenesis starts, Pax2 and Wnt1 are expressed in broad overlapping 
domains [15]. Wnt1 expression is largely restricted to the Otx2-positive territory [16], 
whereas Pax2 expression crosses the Otx2/Gbx2 border [17]. Shortly after, at 3-5 
somite stages, the transcription factors En1, En2 and Pax5 are expressed across the 
Otx2/Gbx2 border. The secreted factor Fgf8 is expressed in the caudal Gbx2-positive 
side of the mid/hindbrain boundary.  
Subsequently, the Otx2/Gbx2 boundary is sharpened precisely at the mid/hindbrain 
boundary [14]. Wnt1 and Fgf8 expression areas are refined to narrow rings at the 
anterior and posterior sides of the mid/hindbrain boundary respectively. En1 and En2 
are expressed in gradients that decrease anteriorly and posteriorly from the isthmus 
[19]. Pax5 and Pax8 are expressed across most of the mid/hindbrain domain, while 
Pax2 expression is restricted to a concise region caudal to the Otx2 expressing cells 
[15].  
Fig. 1: Dynamics of gene expression patterns at the mid/hindbrain border. 
Dorsal views of the mouse embryonic neural plate at the (a) 0-somite stage, (b) 6-somite stage and (c) E10 stage, anterior to 
the top. (Ms, Mesencephalon; Mt, ;etencephalon; P, Prosencephalon; r, rhombomeres; hatched line, axis of symetry). The 
position of the mid/hindbrain boundary is indicated by an arrow (from15). 
 
 
1.2.2. Gene regulation in the mid/hindbrain boundary 
 
It is obvious that the expression pattern of the genes expressed in the mid/hindbrain 
boundary is highly complex and is only beginning to be elucidated. “Loss-of-function” 
and “Gain-of-function” studies in mouse, fish and chick systems have brought some 
insight into the function of mid/hindbrain marker genes. 
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The position of the mid/hindbrain boundary is defined by the border between 
Gbx2 and Otx2 expression regions 
 
Otx2 “gene dosage” experiments lead to posteriorization of anterior brain structures. 
For example, midbrain and posterior forebrain are transformed in cerebellum [20, 21]. 
Upon the loss of Otx2 expression in the midbrain, the expression domains of Gbx2, 
Fgf8, Wnt1 and En1 expand anteriorly into the posterior forebrain. Fgf8 and Wnt1 
expression areas also move anteriorly 
Conversely, Gbx2 -/- mutants lack anterior hindbrain tissue derived from rhombomere 
1 -3 [13]. Fgf8 and Wnt1 expression domains are also shifted posteriorly into r3. In 
the embryos that misexpress Gbx2 in the midbrain from a Wnt1 promoter, the caudal 
limit of Otx2 is shifted anteriorly [23]. In any case the new Otx2/Gbx2 border mimics 
the mid/hindbrain boundary and determines the expression domains of Wnt1 and 
Fgf8 [11]. These studies and other misexpression studies [23, 24, 25] indicate that 
there is a mutual repression between Otx2 and Gbx2 and that their common 
expression border determines the position of the isthmic organizer [14]. 
 
 
Fgf8 plays a key role in isthmic signalling 
 
The positioning of the mid/hindbrain boundary is strongly dependent on the Otx2 and 
Gbx2 expression border [11]. However, knockout experiments, where Otx2 and Gbx2 
homozygous null mutants were used [26, 13], showed that Fgf8 was still expressed 
in the mid hindbrain boundary indicating that its expression is not dependent on the 
Otx2 or Gbx2 expression. Further experiments demonstrated that Fgf8 is expressed 
independently of Pax5 [27], Pax8 [28], En1 and En2 [11]. This was not the case for 
Wnt1. In Wnt1 -/- mutants brain development and Fgf8 expression are normal until 
the 6 somite stage, but at the 14 somite stage the mesencephalon is completely lost 
and metencephalic Fgf8 is abolished. This indicates that Fgf8 induction is 
independent of Wnt1, but maintenance needs Wnt1 or a secondary mesencephalic 
signal [21]. 
Other experiments showed that ectopic Otx2 in the hindbrain inhibits Fgf8 in the cells 
in which it is expressed and facilitates the expression of Fgf8 in adjacent Gbx2 and 
Pax2 expressing cells. Conversely, ectopic Gbx2 induces Fgf8 expression in the 
 - 9 - 
anterior midbrain but only in Pax2 expressing cells. Pax2 -/- mice do not express 
Fgf8 from the 2 somite stage on. Thus, Pax2 seems to induce Fgf8 in the 
mid/hindbrain region, however, in the midbrain region Fgf8 is blocked by Otx2. In the 
hindbrain Otx2 is blocked by Gbx2, thus enabling Fgf8 induction [29]. Fgf8 is also 
involved in gastrulation. This further restricts the use of Fgf8 -/- mutants. However, 
mutants with highly reduced Fgf8 amounts were obtained [31, 32]. These mutants 
survived gastrulation and showed relatively mild phenotypes, such as, lack of 
olfactory bulbs and lack of the isthmic constriction and cerebellum.  
Ectopic expression experiments can be done by introducing Fgf8 soaked beads in 
various parts of the brain. The same results as obtained by isthmic tissue 
transplantation [33] are obtained, that is, midbrain structures are built in the 
telencephalon by the addition of Fgf8 soaked beads. Likewise, ectopic En2, Fgf8 and 
Wnt1 could be detected in the caudal vicinity of the beads. [37] 
When the Fgf8 isoform was expressed by the Wnt1 promoter in mice, the Fgf8 
expression region was expanded into the caudal mesencephalon and En2 was 
induced in the midbrain but not En1. Furthermore, both mesencephalon and caudal 
diencephalon displayed a phenoptype of massive proliferation [21]. Different effects 
were obtained when the Fgf8 isoform Fgf8b was misexpressed. In this case the 
midbrain was transformed into an anterior hindbrain fate [34]. Other Fgf family 
members (Fgf17 and Fgf18), which display high homology and similar expression 
patterns to Fgf8 (35, 36) were found later and are supposed to complement Fgf8 
function in the isthmus [11]. Fgf8-beads implanted in the hindbrain induce En1, En2 
and Pax2 and repress Wnt1. In the hindbrain Fgf8 is also involved in the regulation of 
Hox-gene expression which patterns the individual rhombomeres [38]. 
Fgf8 has also been proposed to function upstream of Gbx2 and Otx2 in the 
mid/hindbrain signalling cascade. Fgf8 is expressed earlier in development in axial 
mesodermal cells that lie beneath the presumptive isthmic region of the neural 
plate[37, 39] and that have the capacity to induce En expression [40,41]. In mouse 
experiments it was shown, that Fgf8 soaked beads can induce Gbx2 and repress 
Otx2 in diencephalic explants [34]. Similar results were obtained in chick: Fgf8-beads 
in prosomere 1 or in the anterior midbrain repressed Otx2 [42] and induced Gbx2 [43] 
in adjacent cells and induced cerebellar tissue in the vicinity of the beads and 
midbrain at a distance [37, 42]. 
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Other proteins involved in isthmic signalling: Wnt1, En1, En2, Pax2 and Pax5 
 
“Loss-of-function” experiments showed that Wnt1, En genes and Pax genes are 
essential for the development of midbrain and cerebellum [9]. Wnt1 and En1 -/- mice 
die at birth and have deletions of the cerebellum and midbrain [45, 46, 47]. In 
contrast, Pax5 and En2 display less severe brain phenotypes [48, 49]. In Pax5 -/- 
mice or zebrafish treated with Pax antibodies the isthmus is deleted [48, 50]. 
Combined inactivation of Pax2 and Pax5 in the mouse results in complete loss of the 
mid/hindbrain region. 
En1 and En2 are expressed in gradients that decrease anteriorly and posteriorly from 
the isthmus [19]. As transplanted mid/hindbrain boundary tissue induces En 
expression, En appears to be regulated by signals from the isthmus [33]. Wnt1 is 
supposed to be involved in En expression maintenance but not in induction, since En 
is first expressed and then progressively lost in Wnt1 -/- mice [53]. In Pax5 -/- mouse 
mutants or zebrafish treated with Pax5 antibodies the expression of both Wnt1 and 
En2 was repressed, suggesting their direct positive regulation by the Pax genes. 
[45,50]. Mutations of some putative Pax-binding sites of En2 lead to a complete loss 
of the mid/hindbrain region [54]. Beside of these factors Engrailed is also regulated 
by Fgf8 as described above. 
En1 is expressed slightly earlier than En2 [52, 55]. As En2 cDNA expressed from the 
En1 locus creates complete rescue of the severe En1 phenotype [55], the different 
phenotypes of En1 and En2 mutations are supposed to reflect only differences in the 
temporal and spatial expression of the respective proteins but not a divergence in 
their biochemical activity [9]. Misexpression of En1 or En2 or Pax2 or Pax5 in the 
chick, fish or frog diencephalon leads to the induction of Fgf8 and other expected 
mid/hindbrain marker genes [45, 46, 47, 48]. 
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1.3. Detecting Fgf8 and Pax2 target genes 
 
1.3.1. Strategies for the detection of target genes in vivo 
 
One commonly used technique to detect target genes is misexpression [2]. The 
putative transcription factor is expressed in an environment spatially or temporally 
distinct to its natural expression environment. This can be achieved by fusing the 
DNA containing the putative transcription factor to a foreign promoter. This promoter 
can be constitutively active (CMV...) [3]. In this case the putative transcription factor 
is expressed all the time. This system has several disadvantages. On the one hand 
expression of the putative transcription factor can be lethal in embryonic stages 
before the stage of interest. Another disadvantage could be the effect of the putative 
transcription factor in regions of the embryo different to the investigated regions. This 
could lead to confusing phenotypes. Tissue specific promoters or ectopically 
regulated promoters could help to overcome this problem [4].    
 
For the detection of target genes, the mRNA of the potential target gene is detected. 
Several techniques were developed, such as Northern Blots, RTPCR, real time PCR 
and in situ hybridisation [5, 6]. However, even if the expression of the putative target 
gene is spatially and temporally fully regulated by external factors, it remains a 
challenge to distinguish primary and secondary target genes. Blocking protein 
synthesis by addition of cycloheximide [7] inhibits protein synthesis and can hinder 
the cell to translate the primary target genes and subsequently transcribe the 
secondary target genes. But the cycloheximide could also interfere with the 
translation of the putative transcription factor leading to confusing results.     
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1.3.2. Description of the project 
 
To overcome the problems described above we designed the following system. 
 
Chick electroporation. 
 
Manipulation of chick embryos is easy in comparison to other animals [22]. The egg 
can be opened or closed at different stages of the embryonic development. 
Electroporation of chick embryos [30] allows introducing the DNA into a specific 
region of the embryo. 
 
The Rapalog system  
 
Rapalog is a non toxic molecule that easily passes the cell wall and interacts with two 
different protein domains, the FR-domain and the FK-domain holding them together. 
If the DNA binding domain of a transcription factor is fused to FK and the 
transactivation domain is fused to FR, and both proteins are expressed from different 
loci, no functional transcription factor is formed. On the other hand, if Rapalog is 
added, both transactivation domain and DNA binding domain are brought together 
and a functional transcription factor is made. Fig. 2 illustrates how the Rapalog 
system works.  
- 
rapalog (non functional)   +rapalog (functional)   
Fig. 2: Rapalog can be used to bring two domains together and build a functional protein. 
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If a translation inhibitor, such as Cycloheximide (CHX), is added before Rapalog 
addition, no further translation can occur when the putative target genes are 
activated and the mRNA synthesized specifically after Rapalog addition belongs to 
direct target genes of the tested (Rapalog inducible) transactivator, and not to a 
potential (secondary) transactivator encoded by any of the target genes (Fig. 3). 
 
 
 
Fig. 3: Schematic representation of the use of the Rapalog expression system to identify novel target Genes. DNA 
sequences (straight lines), mRNA (curved lines), DNA-binding domain-FK (turquoise squares), transactivation domain-FR 
(turquoise circle); Rapalog (black square), direct target genes (red and blue); secondary target genes (pink), not expressed  
genes (green); genes expressed endogenously by a different transactivation factor (black). If no Rapalog is added, only the 
mRNA of genes expressed endogenously is present. The inducible transactivator, that would enable expression of the blue and 
red genes is not active because its two domains are not together. If Rapalog is present, the two domains of the inducible 
transactivator (DNA-binding domain (square) and transactivating domain (circle)) are joined and the protein becomes functional. 
mRNA from the red and blue genes is produced, but, if the proteins encoded by this genes are also Transcription factors, 
secondary genes(pink), that can be activated by potential Transcription factors encoded in the red and/or blue genes, are 
transcribed (pink mRNA). If Cycloheximide is added before Rapalog addition, no translation can occur and no secondary 
transactivator can be built. Therefore no secondary mRNA can be produced. 
 
+Rapalog 
+CHX 
RNA transcripts RNA transcripts 
+Rapalog 
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A similar system can be used to control dimerization of a membrane bound receptor. 
In our case the FgfR1 receptor was fused to the FK domain. As a monomer, FgfR1 
does not induce the signalling cascade [51]; if it dimerises, it induces the full signal 
transduction cascade. An artificial derivative of rapamycin is able to bind to two FK 
domains. Addition of this derivative to cells, whole embryos or parts of embryos leads 
to dimerization of FgfR1 and therefore induces Fgf8 induced signal cascades. With 
this system Fgf8 mediated induction can be artificially activated. The system is shown 
in Fig. 4. 
 
 
 
 
Fig. 4: Inducible Fgf-receptor. Red dots symbolize the artificial derivative of rapamycin. 
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The project 
 
DNA encoding the DNA binding domains of Pax2 or Pax5 are fused to DNA encoding 
the FK domain and placed downstream of the CMV promoter [3]. CMV is a very 
strong constitutive promoter that works in all tissues. On another plasmid a strong 
transactivation domain encoding DNA is fused to FR DNA and also placed under the 
control of the CMV promoter. 
Both plasmids are electroporated together into the mid-hindbrain region of chick 
embryos. After leaving the embryos to recover from the electroporation shock, the 
embryos are cut out and cultivated. Due to the electroporation, both proteins, 
transactivation domain-FR and DNA-binding domain-FK, are produced at high 
amounts but are not functional. Finally the Rapalog derivative and Cycloheximide are 
added. Cycloheximide abolishes de novo protein synthesis but does not inhibit the 
already translated proteins to work. On the other hand, the Rapalog derivative fuses 
the DNA-binding domain-FK and the transactivation domain-FR to a functional 
transcription factor that binds on target genes and starts transcription. Because of the 
presence of Cycloheximide the newly transcribed RNA cannot be translated, and 
secondary transcription factors cannot be produced. Hence, differences in amount of 
RNA of several genes after addition of Cycloheximide and the Rapalog derivative are 
a direct consequence of the Rapalog activated transcription factor. Figures 3 and 5 
give a short illustration of the project. 
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Step 1: Introduction of overexpressing vectors into the mid/hindbrain boundary of the 
chick-embryo by electroporation. 
       
 
 
Step 2:  Cultivation of the electroporated embryo in the egg for 24 or 48 hours, 
respectively. 
 
Step 3: The embryo is cut out from the egg and incubated in non restrictive 
medium. The embryo is either submerged as a whole into the medium or 
the mid/hindbrain-boundary is cut and transferred to a filter on the surface 
of the medium, with addition or not of the rapalog derivative and 
cycloheximide. 
 
  
 
 
 
Step 4: The embryo is analysed by different methods (DNA hybridisation, LacZ 
staining, etc.) 
 
Fig. 5: Illustration of our project 
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2. Materials and Methods 
 
Abbrevaitions used in this chapter:  
 
RT..... room temperature 
o/n......overnight 
EtOH. ethanol 
 
 
2.1. Cloning 
 
 
2.1.1. List of plasmids 
 
pMClacZ: This plasmid contains the β-galactosidase ORF (lacZ) under control of the 
CMV promoter. The lacZ should be expressed in high amounts constitutively in 
vertebrate cells. This plasmid was used to check electroporation efficiency and 
location of the transgene expression. (The number of the plasmid in Czerny’s 
collection is 856.) 
 
pCMVRluc: This plasmid contains the ORF of the Reneal Luciferase (Rluc) gene 
under the control of the CMV promoter. The CMV promoter is a very strong promoter 
that is supposed to transcribe the Rluc gene constitutively. This plasmid was co-
transfected or co-electroporated and used to determine the efficiency of the DNA-
transfer. (The number of the plasmid in Czerny’s collection is 694.) 
 
pMCluc: This plasmid contains the ORF of the Firefly Luciferase (luc) gene under the 
control of the CMV promoter. Like pCMCRluc this plasmid expresses constitutively 
the Firefly Luciferase gene in high amounts. As we should use the Luc gene as a 
reporter, we used this plasmid as a positive control to ensure that Luc is well 
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expressed in the organisms we tested. (The number of the plasmid in Czerny’s 
collection is 642.) 
 
pMCPDVP16: This plasmid contains a fusion protein of the “Paired domain” [57] of 
Pax2 and the VP16 transcriptional transactivating domain [58]. This gene is under 
control of CMV promoter to ensure that it is expressed in high amounts constitutively. 
The PDVP16 fusion protein should bind at all enhancer regions where Pax2 binds 
and activate strong transcription of the genes downstream. This plasmid should be 
used to identify the genes that contain a Pax2 binding site on their promoter. (The 
number of the plasmid in Czerny’s collection is 714.) 
 
pMCPDFK: This plasmid contains the Paired Domain of Pax2 fused to three Rapalog 
binding domains. This plasmid was part of the Rapalog inducible system. The PDFK 
protein is under control of the CMV promoter and should therefore be constitutively 
expressed in high amounts. Together with plasmid pMCFR65 it should provide a 
system that enables expression of all ORFs downstream of a Pax2 binding sequence 
when Rapalog is added to the cells. As PDFK contains three FK domains three 
transactivation domains should be able to be coupled to PDFK. This leads to an even 
stronger expression of the target gene. (The number of the plasmid in Czerny’s 
collection is 1007.) 
 
pMCFR65: This plasmid contains a strong viral transactivation domain fused to the 
Rapalog binding FR domain. Rapalog shoud couple the strong P65 transactivation 
domain to the PDFK protein expressed by pMCPDFK. This should lead to a strong 
transcription activity of all genes downstream of a “Paired domain” binding site. If 
Rapalog is absent, no transcription should occur because the transactivation domain 
(P65) is not coupled to the DNA binding domain (PD). (The number of the plasmid in 
Czerny’s collection is 897.) 
 
pMluc12Pax: This plasmid contains the Pax consensus binding site followed by the 
Firefly luciferase ORF. The Firefly luciferase should be expressed if a DNA binding 
protein able to bind to the  Pax consensus binding region (like Paired Domain) 
contains also a strong transactivation region (like VP16 or P65). Plasmid 
pMCPDVP16 should therefore lead to expression of Luc while pMCPDFK together 
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with pMCFR65 should express Luc when Rapalog is added but not when it is absent. 
This plasmid was used as a reporter to test whether transcription of genes 
downstream the PD binding site are really activated by PDVP16 or 
(PDFK+FR65+Rapalog) (The number of the plasmid in Czerny’s collection is 794.) 
 
pMCFgfFK: This plasmid contains the Fgf-receptor gene [51] fused to the 
Rapamycin binding FK domain. Addition of Rapamycin derivate leads to dimerization 
and thus activation of the Fgf-receptor even if no Fgf factor is present. This plasmid 
was used to identify changes of the transcription pattern of a cell in response to Fgf-
induction (The number of the plasmid in Czerny’s collection is 1035.) 
 
2.1.2. DNA-Preparation 
 
Mini Prep. 
 
1.  Inoculation of 2-3 ml LB with an E.coli colony. 
2.  O/n incubation at 37°C, shaking 
3.  Centrifugation of 2 ml culture volume at 5000 rpm for 2 min 
4.  Pellet was resuspended in 200 µl P1  
5.  200 µl P2 were added and cautiously mixed  
6.  Incubation for 5 min at RT 
7.  Addition of 200 µl P3. 
8.  Centrifugation for 15-20 min at 14000 rpm. 
9.  Transfer of the supernatant to a new Eppendorf tube 
10. Precipitation of DNA with PEG or EtOH 
11. Pellet was resuspended in 20 µl 10 nM Tris pH 7.5 
 
P1: 500 mM Tris-Cl pH7.5;  
 10mM EDTA pH 8.0 
 0.05 mg/ml RNase A 
 
P2: 0.2 M NaOH 
 1% SDS 
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P3: 3 M KAc 
 glacial acetic acid to pH 5.5 
 
PEG precipitation:  
1. Add same volume of DNA solution of PEG 24% (24% polyethylenglycol 6000, 
3 M NaCl) 
2. Shake at 37 ° C for 15 min. 
3. Centrifugation for 15 min at 1500g, 4 ° C 
4. Wash pellet with 70 % EtOH 
     
EtOH Precipitation: 
1. Add NaCl to DNA solution to a final concentration of 300mM 
2. Add double volume of EtOH abs. 
3. Incubate 20 min at -20 °C 
4. Centrifugate for 20 min at 4 ° C 
5. Wash pellet with 70% EtOH 
 
Midi Prep: 
 
Midi Prep was performed with Plasmid Midiprep Kit Jetstar (Genomed) as described 
in the instructions. 
 
2.1.3. Bacterial stocks 
 
1 ml bacterial culture was mixed with 110 µl 10x Hogness ( 36 mM K2HPO4, 13 mM 
KH2PO4, 20 mM Na3-Citrate, 10 mM MgSO4, 50% glycerol in H2O des., sterilised by 
filtering) and stored at -80 °C 
 
2.1.4. Qualitative and quantitative analysis of DNA 
 
Agarose gel electrophoresis:  
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Separation of fragments was usually performed on a 1% agarose gel with 10 µg/ml 
ethidium bromide and TAE buffer. DNA samples were mixed with DNA loading buffer 
before application on the gel. 
1xTAE: 40mM Tris-acetate, 2 mM EDTA 
5xDNA loading buffer:  20% Ficoll 400, 0.1 M EDTA, 1% SDS, 0.1% bromphenol 
blue, pH 8.0. 
Marker for DNA fragment length and semi-quantitative analysis of DNA amount: 100 
bp DNA ladder (Fermentas), 1 kb Plus DNA ladder (Gibco). 
DNA was visualised on Eagle Eye II (Stratagene) 
 
 
Quantification of DNA:  
 
was performed spectrophotometrically by measuring the UV-adsorption at 260 nm. 
 
 
Sequencing: 
 
Cloned plasmids were controlled by sequencing. For the sequencing reaction, 500 ng 
DNA were mixed with 5 pmol primer and 2 µl DYEnamicTMET terminator cycle 
sequencing kit (Amersham Pharmacia) in 10 µl final volume. The cycling reaction 
was performed in the PCR machine as follows: 
 
96 ° C  10 s 
50 ° C 5 s              25 cycles 
60 ° C 4 min  
 
For precipitation of sequencing products, 62 µl Preci Mix (50 µl EtOH abs, 2 µl 3 M 
Na-actetate pH 4.6, 10 µl H2O dest) were added and the mixture was centrifugated at 
14000 rpm, 4 ° C for 30 min. Pellet was then washed with 100 µl 70% EtOH and 
dried in “speed vac.” Pellet was then dissolved  in 3 µl loading buffer ABI. 1.5 µl were 
denatured at 95 ° C, 2 min and then loaded on a sequencing gel. 
 
 
}   
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1ml loading buffer ABI: 800 µl formamide deionised 
 10 µl 0.5 M EDTA 
 190 µl H2O dest. 
 blue dextran. 
 
Sequencing machine:  ABI PRISM 377 (Applied Biosystems) 
 
Primers used for sequencing: 
T7 5’-TAATACGACTCACTATAGGG-3’ primer for pMC expression vector 
TS 1 5’-AGCTTAGAGACTCCATT-3’ primer for pMC expression vector 
TS 183 5’-GATCTGATCTCGGAGAT-3’ primer for FgfR1 coding vector 
 
2.1.5. Enzymatic reactions with DNA 
 
Restriction enzyms and buffers from Fermentas/MBI and Gibco. Buffers were used 
as recommended. 5 µg DNA were usually digested with 2 µl enzyme (~20 units) for 1 
hour at 37 ° C or 30 ° C, as recommended. DNA was separated from enzymes by gel 
purification from a 1% agarose gel with Clean Mix kit (Talent). 
T4 recession of 3’ overhangs with 10 units T4 DNA polymerase (Fermentas) per 10 
µg plasmid DNA in restriction enzyme buffer, 0.1 mM dNTPs (Fermentas). 
Preparation on ice, incubation for 20 min at 11°C, inactivation for 10 min at 75°C. 
5’ overhangs were filled with 10 mM dNTPs by 5 units klenow fragment of DNA 
polymerase I (Fermentas) for 1 hour at room temperature (RT). Inactivation at 65°C 
for 20 min or removal by gel purification. 
Dephosphorylation of vector DNA with calf intestinal phosphatase (CIP) from Gibco. 
5 µg plasmid DNA in restriction enzyme buffer were incubated with 0.1 units for 5’ 
ends and 5 units for 3’ ends of CIP for 2x15 mins at 37 °C. Addition of enzyme in two 
steps.  Removal of enzyme by gel purification. 
Kinasing of 1-20 pmol oligos with 10 units T4 polynucleotid kinase (Fermentas), 10 
mM rATP (Fermentas) in Buffer A (Fermentas) for 1 hour at 37 °C. Oligo annealing 
and kinase inactivation in initially boiling water bath, cooling down slowly. 
In vitro mutagenesis with 100-300 ng plasmid DNA, 200 nM primer, 200 µM dNTPs, 
1.25 units Pfu polymerase (Stratagene) in Pfu Buffer (Stratagene). 
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The cycling reaction was performed on the PCR machine (M J Research/PTC-200 
Peltier Thermal Cycler): 
 
95°C 3 min 
95°C 15 sec 
55°C 1 min         18 cycles 
68°C 12 min 
 
Then digestion with 1 µl DpnI (5 units; Gibco) at 37°C for 2 hours (after 123). 
 
Ligation of 30 fmol vector fragment and 60 fmol insert with 2 units T4 DNA ligase 
(Fermentas) in ligation buffer (Fermentas) o/n or at least 5 hours at 14°C for sticky 
ends and 22°C for blunt ends. Inactivation after 5 hours incubation time at 65°C for 
10 min. 
PCR from 10 ng template DNA with 50 pmol of each primer  (Gibco), 200 µM dNTPs, 
2.5 units Taq polymerase (Fermentas), 10x PCR Buffer (50 mM KCl, 10 mM Tris pH 
8.3, 1.5 mM MgCl2 in 50 µl. 
PCR program: 
94°C 5 min 
94°C 30 sec 
55-65°C 30 sec                                        30 cycles 
72°C 30 sec + 1 min for each kb 
72°C 5 min 
2.1.6. Transformation of E. coli 
 
Preparation of competent E.coli cells (DH5a, Sure (Stratagene), Top 10 F’ 
(Invitrogen)) as described in [10]. 
 
Transformation 
 
100 µl competent cells were added to plasmid DNA after ligation. Incubation on ice 
for 10 min. Heat shock 1.5 min at 42°C. Incubation with 1 ml LB at 37 °C, shaking, for 
1hour. Centrifugation at 5000 rpm for 3 min. Supernatant was removed, pellet 
resuspended and plated on LB-amp. Incubation of plates o/n at 37°C. 
} 
} 
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1l LB: 1 0 g bacto trypton 
 5 g yeast extract 
 5 g NaCl 
 1 ml 1M NaOH 
 to 1 l H2O dest 
 autoclaved 
LB-amp: Ampicilline was added to a final concentration of 100 µg/ml. 
1l LB agar:10 g bacto trypton 
 5 g yeast extract 
 5 g NaCl 
 1 ml 1M NaOH 
 15 g Agar agar 
  to 1 l H2O dest 
 autoclaved 
Before pouring plates, LB agar was boiled shortly, cooled down to 50°C, and 
ampicilline was added to 100 µg/ml final concentration. 
 
2.2. Chicken culture and Electroporation 
 
Solutions needed 
 
• 70 % EtOH 
• PBS: NaCl 1.37 M, KCl 27 mM, Na2HPO4 43 mM, KH2PO4 14 mM, pH 7.4 
• PTw (PBS/Tween): 0.1% w/v Tween20 in PBS 
• PFA 4%: 4% w/v paraformaldehyd in PTw 
• PBS/PS: 10x PenStrep (Gibco) in PBS 
• DME: Dulbecco's modified Eagle medium.[56] 
• 1M NaOH 
• FCF (Fast green) 
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Preparation of eggs:  
 
Fresh eggs can be stored at 8° for up to 2 weeks. Two days before electroporation 
eggs were placed on their side in the egg holder in the incubator at 38.5° (for short 
time incubation no rolling is necessary). After 48h the embryos reach HH10 (10 
somites). The egg was removed from the incubator without changing its orientation 
and swabbed with 70% EtOH. Hands were desinfected similarly. 
 
 
Opening of eggs 
  
The egg was penetrated on the top and then 4 to 5 ml of albumen were removed (for 
long term incubation of eggs 1,5 to2,5 ml) from the blunt end of the egg with a 
0,9/40mm needle without damaging the yolk A 3-cm-diameter circle was cut with 
scissors (desinfected with 70% EtOH) and a drop of ice cold freshly prepared 
PBS/PS was applied on the top of the embryo (PBS/PS contains 10x PenStrep 
(Gibco, -20°) diluted 1:10 in PBS). Ink (Pelikan india ink Nr17 diluted 1:20 in PBS) 
was injected with a 0.4/20mm needle (the needle was desinfected after each 
injection with 70% EtOH). Eggs were electroporated immediately after opening. 
 
 
Electroporation 
 
DNA was injected into the neural tube of a 10-15 somite embryo. Electrodes were 
placed on either side of the embryo (electrodes: distance 4mm, length ...., covered 
with nail polish on lower half). A drop of ice cold PBS/PS was added and pulses were 
applied (25V, 6 pulses of 50ms separated by 100ms intervalls, program 1). 
Electrodes were carefully removed and cleaned with PBS and then with 70% EtOH. 
Eggs were covered with parafilm (hands washed with 70% EtOH). Eggs were 
incubate at 38,5° for 24 to 48h. 
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Dissection of embryos: 
 
The parafilm was removed and the embryo, including the embryonic plate, was cut 
out from the egg with dissection scissors. Then it was rinsed in PBS and put on a 
PBS filled durex dish. The non embryonic parts were removed with a wolfram needle 
under the microscope. The hart was also removed and the neural tube was opened. 
The prepared embryo was either fixated directly or parts of it were transferred to a 
membrane (explants) and incubated in DME full medium at 37°C o/n, with or without 
rapalog cycloheximide. 
Sharpening of the wolfram needle; 
The wolfram needle was sharpened by dipping it into a 1M NaOH solution under 
current. The stronger the current was, the faster the sharpening. The anode was 
connected to the needle and the cathode was connected to the NaOH solution. 
 
 
Fixation of embryos in 6-well plates: 
 
Embryos were transferred to wells and 4-6 ml PFA 4% per well was added for 
fixation. Embryos were incubated 1-2 h at room temp. or o/n at 4°C. Then they were 
washed twice with PBS and transferred to methanol (100%) in 24-well plates and 
stored indefinitely (but at least o/n) at -20°C. 
 
Preparation of injection needles: 
 
Flaming/Brown horizontal needle puller (Sutter Instr. model P97) and capillaries of 
1mm (Clark Instr., GC100-10 borosilicate glass, standard wall without filament, 1.0 
mm O.D. x 0.58 mm I.D) were used. Settings (Program 81): pressure 500, heat 580, 
pull 60, vel 60, time 200 (in 1 step!). Needles were back-filled (Eppendorf 
microloaders) with the injection solution (5µg/µl DNA in H2O supplemented 1:40 with 
1% fast green FCF) and then opened by breaking the tip with a pair of sharp forceps 
under the microscope. For the Eppendorf microinjector the settings were 3 hPa for 
backhold pressure and 300-1000 hPa for injection pressure and 0.5 sec. The 
injection pressure was adjusted that small but visible amounts of the injection 
solution were released from the needle.  
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Treatment of the equipment: 
 
For incubation of eggs the fan in the incubator had to be turned on and the 
temperature was adjusted to 37.2° (corresponds to 38.5° internal temperature). 
Water reservoir had to be filled and condensed water had to be removed. Before 
incubation incubator was cleaned and desinfected with 70% EtOH 
 
2.3. Analysis of manipulated Embryos  
 
Solutions needed 
 
• PBS: NaCl 1.37 M, KCl 27 mM, Na2HPO4 43 mM, KH2PO4 14 mM, pH 7.4 
• PTw (=PBSTween): ): 0.1% w/v Tween20 in PBS 
• PFA 4%: 4% w/v paraformaldehyd in PTw  
• X-Gal buffer: K3Fe(CN)6 5 mM, K4Fe(CN)6 5 mM, MgCl2 2 mM, 
                           Triton X-100 0.1 % in PBS 
• X-Gal solution: 1% v/w X-Gal in X-Gal buffer 
• Lysis buffer: 1% Triton X-100, 0.25 M Tris pH7.5 1, mM DTT (freshly added) 
• Luciferase solution 1: 0,2 mM luciferin 20mM Tris pH 7 
• Luciferase solution 2: 5 mM ATP (pH 7.0 !), 25 mM Tris pH 7.5, 15 mM MgCl2 
• Reneal Luciferase solution: 1/8 8xStopandGlo Buffer (Promega, 1/100 
                                                 substrate (Promega). All diluted in H2O 
• Phenol 
• CHCl3 
• NaCl 
• RNase free water (DEPC) 
• Electrophoresis loading dye for DNA and RNA 
• DNA and RNA gel-markers 
• in vitro transcription kit (Dig or FITC marked nucleotides) 
• RNase free DNase 
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• 10 M NH4Acetate 
• EtOH abs 
• EtOH 70% 
• Methanol 
• Proteinase K 
• Hyb-Mix: Formamide 50%, SSC 5x, Heparin 0.15mg/ml, Torula-RNA 5mg/ml, 
                Tween20 1% all dissolved in DEPC 
• 4x SSCT: NaCl 0.6 M, Na3citrate 60 mM, pH 7.0 
• Anti-Dig and/or Anti-FITC antibodies 
• Waste embryos for antibody preabsorbation 
• Staining solution:  4.5 µl NBT (75 mg/ml in 70% DMF) + 3.5 µl BCIP (50 mg/ml  
                              in 100% DMF) per ml AP-buffer 
 
 
2.3.1. lacZ-staining 
 
Embryos were fixed for 15 min with PFA 4% (4% w/v in PBSTween (0.1% v/v 
Tween20 in PBS)) and washed in PBS for at least 30 min Then PBS was replaced 
with X-Gal solution (1% v/w in X-Gal buffer (K3Fe(CN)6 5 mM, K4Fe(CN)6 5 mM, 
MgCl2 2 mM, Triton X-100 0.1 % in PBS). The embryos were kept at 37° for 30 min to 
several hours. The reaction was stopped by replacing X-Gal solution with PBS 
 
 
2.3.2. Luc Assay 
 
100 µl lysis buffer (1% Triton X-100, 0.25 M Tris pH7.5 1, mM DTT (freshly added) or 
5x Passive Lysis Buffer (Promega) 10x diluted if Rluc has to be determined after 
minimum time of 5 minutes (15-20 minutes)) was added to the embryos. Then the 
embryos were mashed with a pistil in an Eppendorf tube until the solution was as 
homogeneous as possible.  
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For Firefly luciferase activity measurements: 
 
Solution I (100 µl for 1 reaction + 600 µl for initial wash): 
0,2 mM luciferin 20mM Tris pH 7. 
Solution II (100 µl for 1 reaction + 600 µl for initial wash): 
5 mM ATP (pH 7.0), 25 mM Tris pH 7.5, 15 mM MgCl2  
Solutions I and II were placed in their corresponding places in the luminometer. 30µl 
of the mashed embryos were used for measurements (program 1). 
 
 
For Reneal luciferase activity measurements: 
 
Solution (100 µl for 1 reaction + 600 µl for initial wash): 
Stop&Glo buffer (Promega Dual Luciferase Assay) was diluted 1 to 8, substrate 
(Promega Dual Luciferase Assay) was diluted 1:100 in H2O 
The solution was placed in its corresponding place in the luminometer and 10µl of the 
mashed embryos were used for measurement (program 2) 
 
 
2.3.3: In situ hybridization: 
 
All solutions used for In situ hybridization were prepared with DEPC water!!! 
 
 
Preparation of probes for In situ Hybridization: 
 
I. Linearisation of template: 
10 µg plasmid were digested with 5µl enzyme (should generate 5’ overhang!) in 100 
µl for 2 hrs (to O/N). Then H2O was added up to 150 µl. Then 75 µl phenol were 
added intensively vortexed. Then 75 µl CHCl3 were added and vortexed again, 
centrifuge and the upper phase (without interphase) was mixed with 150 µl CHCl3, 
vortexed centrifuged and again taken. NaCl was added to a final concentration f 0.3 
M and precipitated with 2 vol. EtOH, centrifuged and washed with 70% EtOH.  
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The pellet was dissolved in 20 µl RNase free water. 0.5 µl were used for a control 
gel; they were mixed with 5 µl H2O and 2 µl loading dye and loaded on a gel.  
II. In vitro transcription: 
 rNTPs-Dig-Mix for 1 reaction: 
2µl  10mM rATP 
2µl  10mM rCTP  
2µl  10mM rGTP 
1.3 µl  10mM rUTP 
0.7µl  10mM Dig-rUTP 
(8µl / reaction)  
1µg  linearized DNA (RNase free)  
4µl  5 x trancription buffer 
8µl  rNTPs-Dig- Mix  
0.1 µl  (=5U) RNase inhibitor  
1µl  RNA polymerase (20u/µl) add RNase free H2O to 20µl  
Incubate 1 hour at 37 °C for T7 and T3 (2 hrs for SP6)  
III. DNaseI digestion: 
1 µl RNase free DnaseI (Fermentas, 2U/µl) was added and incubated 15 min at 
37°C. 
The reaction was stopped by adding 1 µl RNase free 0.5 M EDTA. 
IV. Isolation of RNA: 
130 µl DEPC H2O and 50 µl NH4Ac 10M and 400 µl EtOH were added to the mix. 
Then the mix was incubated for 30 min at -20° and centrifuged for 10 min at 4° full 
speed. The pellet was washed with ice cold 70% EtOH and dissolved in 20 µl RNase 
free water. Alternatively it could be precipitated with LiCl (Ambion instructions) 
without phenol extraction (DIG accumulates in the phenol phase). 
VI. Control of concentration und purity (RNA): 
To 0.5 µl of the newly synthesized RNA 4.5 µl H2O and 1µl RNA loading dye were 
added. The mix was denatured at 94°C for 4 min (also 6µl marker), then immediately 
put on ice and loaded on a 0.8 % agarose gel (with DEPC treated water, apparatus 
FOR RNA ONLY).  
RNA loading dye: 5x loading dye including 600 µg Etbr / ml;  
Marker for RNA (max 50 ng bands in 6µl): 10 µl of 100bp ladder DNA stock (0.5µg/µl) 
+ 20 µl RNA loading dye 5x + 70 µl H20 
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After controlling RNA on the gel 100x probe stock solutions were prepared: The RNA 
was diluted to 10-20 ng / µl in DEPC-H20 RNA probes were diluted 1:100 for in situ 
hybridization (1 µl in 100 µl DEPC-H20). For estimation of RNA quality use 5 µl of the 
100x stock (50-100 ng) were loaded on a gel (see before). 
 
Hybridization for single staining 
 
3-5 embryos fixed in PFA + methanol (see ‘chick embryo preparation’) were used per 
well. 
I. Rehydration (all steps at RT on a rocking platform): 
Embryos were incubated each 5 min in 75% methanol/PTW, 50 % methanol/PTW, 25 
% methanol/PTW and 2x in PTW 
II. Proteinase K digestion: 
Proteinase K was used at 10µg/ml PTW for 10 min (HH<17), 15 min (HH17), 20 min 
(HH>17). Then the embryos were rinsed 2x shortly in freshly prepared 2 mg/ml 
glycine/PTW. Then they were washed with 2x PTW  
III. Fixation:  
Embryos were fixed in 4 % PFA/PTW for 20 min and washed 5 x 5 min in PTW. 
IV. Hybridization (o/n): 
Embryos were transferred to 2 ml tubes and prehybridized for 3-4 hours in Hyb-Mix at 
65°C. Then the prehybridization solution was carefully removed (embryos are 
fragile!). Hybridization was carried out o/n at 65°C in 100 - 500 µl hybridization 
solution (10-40 ng antisense probe per 100 µl Hyb-Mix (Formamide 50%, SSC 5x, 
Heparin 0.15mg/ml, Torula-RNA 5mg/ml, Tween20 1% all dissolved in DEPC)). 
V. Washing (all steps at 65°C): 
Embryos were washed 2 x 30 min in 2 ml 50% formamide /2xSSCT, 15 min in 2 ml 
2xSSCT and 2 x 30 min in 2ml 0.2xSSCT. (4xSSCT (0.1 % Tween20 in 4xSSC (NaCl 
0.6 M, Na3citrate 60 mM, pH 7.0)) 
VI. Blocking and antibody reaction (in 6-well plates at RT on a rocking platform): 
Embryos were blocked for 1 - 2 hrs at RT with 1 ml blocking-solution (10% sheep 
serum in PTW.) and then incubated o/n at 4°C with 200 µl blocking-solution + 
preabsorbed Ab (AntiDig-AP Fab fragment 1/5000). or preabsorbed Ab (AntiFITC-AP 
Fab fragment 1/6000). 
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VII. Washing: 
Embryos were washed 5 x 10 min in PTW at RT and 2 x 5 min in AP-buffer. 
VIII. Staining: 
Staining solution; 4.5 µl NBT (75 mg/ml in 70% DMF) + 3.5 µl BCIP (50 mg/ml in 
100% DMF) per ml AP-buffer, Color reaction was developed in the dark and stopped 
by fixing embryos with 4% PFA for 1 hour. Stained embryos were washed 2x for 10 
min with PTW and stored in at 4°. 
 
Preabsorbtion of antibodies: 
Wt embryos of the same stage were fixed in 4%PFA for 1h and 2x washed with PBS 
and then homogenized in 1.5 ml tube + 4 vol ice-cold aceton. They were kept for 30 
min on ice and centrifuged at full speed for 10 min. The pellet was resuspended 
again in aceton and centrifuged again. Then it was dried on whatman filter. 3mg 
embryo powder was put into a 2ml tube and 0.5 ml sheep serum (10% in PTW) + 1 µl 
antibody were added. The mixture was rotated for 2h at 4°, shortly centrifuged and 
diluted to 10x of final concentration. 
 
 
Hybridization for double staining: 
 
steps I-V see Chick in situ hybridization 1 
 
VI. Blocking and antibody reaction (in 6-well plates at RT on a rocking platform): 
Embryos were blocked for 1 - 2 hrs at RT with 1 ml blocking-solution (10% sheep 
serum in PTW.) and then incubated o/n at 4°C with 200 µl blocking-solution + 
preabsorbed Ab (AntiFITC-AP Fab fragment 1/6000). 
VII. Washing: 
Embryos were washed 5 x 10 min in PTW at RT and 2 x 5 min in AP-buffer.  
VIII. Staining: 
Staining sol; fast red tablet in 10 ml Tris 0.2M pH 8.0, Naphthol tablet in 10 ml Tris 
0.2M pH 8.0; both solutions were mixed and added to embryos. Red color reaction 
was carried out in the dark. 
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IX. Stripping: 
Embryos were washed 3x 10 min in Glycine-HCl 0.1M pH 2.2, 0.1% Tween and 4x 5 
min in PTW. 
X. Secondary antibody reaction: 
Like in step VI, but with preabsorbed AntiDig-AP Fab fragment 1/5000 o/n at 4°C with 
200 µl blocking-solution. 
XI. Washing: 
like step VII. 
XII. Staining: 
Staining solution; 4.5 µl NBT (75 mg/ml in 70% DMF) + 3.5 µl BCIP (50 mg/ml in 
100% DMF) per ml AP-buffer Color reaction was developed in the dark and stopped 
by fixing embryos with 4% PFA for 1 hour. Then the embryos were washed 2x for 10 
min with PTW and stored in PTW at 4° 
 
Preabsorbtion of antibodies: 
Wt embryos of same stage were fixed in 4%PFA for 1h and 2x washed with PBS and 
then homogenized in an 1.5 ml tube + 4 vol ice-cold aceton. They were kept for 30 
min on ice and centrifuged at full speed for 10 min. The pellet was resuspended 
again in aceton and centrifuged again. Then it was dried on whatman filter. 3mg 
embryo powder was put into a 2 ml tube and 0.5 ml sheep serum (10% in PTW) + 1 
µl antibody were added. The mixture was rotated for 2h at 4°, shortly centrifuged and 
diluted to 10x of final concentration. 
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3. Results 
 
3.1. Electroporation efficiency experiments. 
 
Before starting to look for the effects of the misexpressed genes (pax2 and fgf8), we 
had to find the optimal conditions for electroporation in chick embryos. We started 
using the conditions described by Itasaki and coworkers [30]. These conditions were 
further adapted by Dr Thomas Czerny and Dr Thomas Heimbucher by experiments 
done before I joined the lab, (detailed description in the methods part). The 
electroporation aparatus was built and programmed by my supervisor Dr Thomas 
Czerny. For our experiments it was very important that the embryo survives the 
treatment, that it develops normally and that the expression of the introduced gene is 
on the one hand restricted to the electroporated area and on the other hand high 
enough to see an effect. 
3.1.1 Tests with lacZ 
 
To test the electroporation efficiency and the expression level and the detectability of 
the gene introduced by electroporation, approximately 1 µg of the plasmid pMClacZ 
carrying the lacZ gene under control of the CMV-promoter were electroporated into 
the neural tube of chick-embryos, that were in the 7 – 10 somite stage. LacZ was 
used because the β-Lactamase activity is easy to detect by incubating the embryos in 
a solution containing X-Gal [18] After electroporation the eggs were incubated for 24 
hours at 37 °C and then the embryos were dissected out off the egg. The embryos 
were fixed in PFA (4% Paraformaldehyd in PTW) for 30 min, then washed in PBS for 
30 min and transferred to X-Gal staining solution (100 µl X-Gal (50 mg/ml in 
dimethylforamid) in 5 ml X-Gal buffer (5mM K3Fe(CN)6, 5 mM K4 Fe(CN)6, 2 mM 
MgCl2, 0.1 % Triton X-100 in PBS)) at 37 °C. After two or three hours the 
electroporated embryos were fixed in PFA o/n at 4 °C and analysed for LacZ staining 
[18]. Figure 6 shows a picture taken from such an embryo. 
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Fig. 6: The blue area (which appears black due to tecnical reason) is the X-gal staining 
 
 
In Figure 6 we can see, that the plasmid was introduced into cells of the embryo’s 
neural tube and the lacZ-gene was expressed in the expected region. 
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3.1.2: Tests with pMCPDVP16 
 
Plasmid pMCPDVP16 expresses a hybrid protein containing the “Paired domain”, 
which binds to enhancer elements of Pax2 regulated genes, and the strong 
transactivating domain of the viral protein VP16, which should turn on transcription of 
these genes. To test whether plasmid pMCPDVP16 was really able to turn on Pax2 
target genes, chick embryos were coelectroporated with plasmid pMluc12Pax. This 
plasmid contains the firefly luciferase gene under control of a paired domain binding 
element. Coelectroporation with pMCPDVP16 should enable binding of the PDVP16 
protein to the enhancer element and thus turn on luc transcription. pMluc12Pax and 
pMCPDVP16 were electroporated together with pMCRluc for the estimation of the 
electroporation efficiency. To determine the expression level of plasmid pMluc12Pax 
the firefly luciferase activity was divided by the Renilla luciferase activity. The 
following tables (Tab. 1-3) summarize the results of several experiments done on 
different days with different concentrations of each plasmid. 
 
Embryo pMCPDVP16 (5µg) pMluc12pax (5µg) R-luc (0.5µg) Activity luc Activity R-luc Quotient 
1 - + + 593200 1449142 0.38 
2 - + + 13228502 2515351 5.25 
3 - + + 3123279 602072 5.15 
4 - + + 1007206 1045622 0.93 
5 - + + 3629286 501788 7.2 
6 - + + 493965 7441121 0.06 
7 - + + 21412960 7172824 2,98 
Average 
(1-7) 
- + + 6212628 2961132 2.09 
8 + + + 3703122 364900 10.13 
9 + + + 29792506 1442554 20.67 
10 + + + 19509892 646735 30.26 
11 + + + 6591839 295362 22,43 
12 + + + 2691822 214988 12,51 
Average 
(8-12) 
+ + + 12457836 592908 21,06 
Induction by pMCPDVP16 compared to pMCluc12Pax alone. 10.08 
Tab. 1: Electroporation of pMCVP16.  “-” indicates that the same amount of Bluescript KS- was electroporated. 
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The first seven electroporation experiments were done only with pMCRluc and 
pMluc12pax. They were done to test the background value the system gives if the 
strong transactivator PDVP16 is absent. This background value (activity luc / activity 
Rluc) was estimated to be 2.09. Addition of pMCPDVP16 raised the activity of the 
firefly luciferase indicating that it binds on the promotor region of pMluc12Pax. On the 
other hand the activity of the Renilla luciferase decreases so that the quotient luc/R-
luc becomes higher (21.06). To determine the expression of the firefly luciferase due 
to the presence of PMCPDVP16, the quotient of luc/R-luc without pMCPDVP16 and 
luc/R-luc with PMCPDVP16 was estimated. (i.e. 21.06 / 2.09) The value was 10.08. 
This means that expression of firefly luciferase under control of a paired domain 
binding element was increased 10 fold if the paired domain containing PDVP16 is 
present. To optimize the expression activated by PDVP16 another series of 
experiments were done using different concentrations (Table 2). 
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Embryo pMCPDVP16 (5µg) pMluc12pax (0.5µg) R-luc (0.1µg) Activity luc Activity R-luc Quotient 
1 - - + 9646 10938 0.88 
2 - - + 1404 2643 0.53 
3 - - + 1440 2563 0.56 
4 - - + 4163 5381 0.77 
Average 
(1-4) 
- - + 4163 5381 0.69 
5 - + + 44589 66712 0.66 
6 - + + 179475 489280 0.36 
7 - + + 69597 151231 0.45 
8 - + + 164831 762387 0.21 
9 - + + 353805 1785160 0.20 
10 - + + 389197 2437480 0.16 
11 - + + 242007 1221067 0.20 
12 - + + 1949128 10085851 0.19 
13 - + + 104360 674623 0.15 
Average 
(5-13) 
- + + 388554 1963755 0.20 
14 + + + 1558393 216696 7,36 
15 + + + 187165 138052 1,38 
16 + + + 408584 199557 2.08 
17 + + + 480888 89187 5.69 
18 + + + 429301 94264 4.78 
19 + + + 618252 898209 0.69 
20 + + + 248743 130535 1.95 
21 + + + 158494 313526 0.5 
Average 
(14-21) 
+ + + 511228 260003 1.99 
Induction by presence of pMCPDVP16 and pMCluc12Pax over presence of pMCluc12Pax alone. 9.95 fold 
Tab. 2: Electroporation of pMCVP16.  “-” indicates that the same amount of Bluescript KS- was electroporated. 
 
Reduction of the amounts of pMluc12Pax and pMCRluc reduced the background 
activity of both (firefly luciferase and Renilla luciferase, samples 1 - 4). However 
addition of pMluc12Pax (samples 5-13) resulted in a reduction of the quotient luc/R-
luc compared to the background. Addition of pMCPDVP16 raised the firefly luciferase 
expression. Induction of firefly luciferase expression by the addition of pMCPDVP16 
was increased 10 fold, like in the experiment done before.  We made a third attempt 
to improve the induction of firefly luciferase by PDVP16. We raised the concentration 
of pMCRluc to 0.5µg. 
Table 3 shows the results. 
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Embryo pMCPDVP16 
(5µg) 
pMCluc12pax (0.5µg) R-luc (0.5µg) Activity luc Activity R-luc Quotient 
1 - - + 833 1976 0.42 
2 - + + 325529 5658726 0.06 
3 - + + 2751040 17550528 0.16 
5 - + + 951868 1590019 0.6 
6 - + + 2876 853263 0.00 
7 - + + 715841 9554564 0.07 
8 - + + 3198254 29708788 0.18 
9 - + + 566688 23481868 0.02 
Average - + + 1306303 12388567.8 0.11 
10 + + + 2632152 384821 6.87 
11 + + + 1447567 646455 2.24 
12 + + + 137043 25003 5.92 
13 + + + 53160 16649 3.57 
14 + + + 1829955 775430 2.36 
15 + + + 789877 186885 4.27 
16 + + + 116939 46356 2.62 
Average + + + 1000956.14 297371.286 3.39 
Induction by presence of pMCPDVP16 and pMCluc12Pax over presence of pMCluc12Pax alone. 30.8 fold 
Tab. 3: Electroporation of pMCVP16.  “-” indicates that the same amount of Bluescript KS- was electroporated. 
 
 
Table 3 shows that the best results for firefly luciferase expression by PDVP16 were 
achieved when the amount of pMCRluc was 0.5 µg. The concentrations of Table 3 
were used for subsequent experiments. 
 
Table (1-3) show that both plasmids can be expressed in chick embryos and that the 
PDVP16 hybrid protein is able to turn on transcription of putative Pax2 target genes. 
Background activity of embryos either lacking the reporter (pMCluc12Pax) or 
pMCPDVP16 is low. However, the best transcription induction activity was achieved 
when 0.5µg of the reporter plasmid (pMCluc12Pax) and 5µg of the “Paired domain” 
expressing plasmid (pMCPDVP16) were used. 
 
3.1.3 Two hybrid experiments. 
 
To check whether the rapalog induced system (see 1.3.2) also works in chick 
embryos, we electroporated pMCPDFK, pMCFR65, pMCluc12Pax and pMCRluc at 
different concentrations. Immediately after electroporation the embryos were cut out 
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from the eggs and transferred to a membrane. The membrane was incubated in 
Dulbecco's DMEM complete medium at 37 °C for 24 hours with or without Rapalog. 
After that the luciferase activity was determined as described before. Plasmid 
pMluc12Pax carries the firefly luciferase gene under control of the paired domain 
binding site. Plasmid pMCPDFK expresses the DNA binding paired domain of Pax2 
fused to the rapalog binding FK domain. This protein should bind to the promoter of 
the firefly luciferase gene of pMluc12Pax but is not able to activate trancription 
because it lacks the transactivation domain if no rapalog is added. If rapalog is 
added, this molecule binds to the FK domain of PDFK and to the FR domain of FR65 
(expressed by pMCFR65). The strong transactivation domain of p65 and the 
promoter binding paired domain are fused by rapalog and this results in trascriptional 
activation of the firefly luciferase of plasmid pMluc12Pax.  Tables 4-6 show the 
results of this experiment.  
 
Embryo 
Rapalog 
(+/-) 
pMCPDFK (1.25µg) and pMCFR65 
(1.25µg) 
pMluc12pax 
(2.5µg) 
R-luc 
(0.5µg) 
Activity luc Activity R-luc Quotient 
1 (+) + + + 7814 18988 0.41 
2 (+) + + + 1789 7625 0.24 
3 (+) + + + 737 1577 0.47 
4 (+) + + + 1767 4910 0.36 
5 (+) + + + 163 476 0.36 
6 (+) + + + 810 7809 0.10 
Average + + + 2180 6897.5 0.32 
7 (-) + + + 4054 8196 0.5 
8 (-) + + + 1526 4584 0.33 
9 (-) + + + 1396 3595 0.39 
10 (-) + + + 2927 6421 0.46 
11 (-) + + + 589 5500 0.11 
Average + + + 2098.4 5659.2 0.37 
Induction by the presence of Rapalog. 0.9 fold 
Tab. 4: Induction by Rapalog.  “(-)” indicates that no Rapalog was added. 
 
In this first experiment we could not detect transcriptional activation by the addition of 
rapalog (probes 1-6). The reason for this was probably the inhomogeous distribution 
of the plasmids. This means that most cells did not contain all the plasmids 
electroporated in the proper amounts. To solve this problem we increased the 
amount of pMCPDFK and pMCFR65 and decreased the amount of pMluc12Pax. 
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This should ensure that the cells containing pMluc12Pax also contain pMCPDFK and 
pMCFR65. Table 5 and 6 show the results. 
Embryo 
Rapalog 
(+/-) 
pMCPDFK (5µg) and pMCFR65 (5µg) PMCluc12pax 
(0.5µg) 
R-luc 
(0.5µg) 
Activity luc Activity R-luc Quotient 
1 (-) + + + 7117 789 9.02 
2 (-) + + + 53588 340 157.6 
3 (-) + + + 4186 360 11.6 
4 (-) + + + 10096 336 30 
Average + + + 18746.75 456.25 52.1 
5 (+) + + + 1087 411 2.65 
6 (+) + + + 16887 280 60.3 
7 (+) + + + 15917 442 36 
8 (+) + + + 27139 425 63.9 
Average + + + 15257.5 389.5 40.7 
Induction by the presence of Rapalog. 1.28 fold 
Tab. 5: Induction by Rapalog.  “(-)” indicates that no Rapalog was added. 
Tab. 6: Induction by Rapalog.  “-“ indicates that the same amount of Bluescript KS- was electroporated. “(-)”indicates that no 
Rapalog was added. 
Embryo 
Rapalog 
(+/-) 
pMCPDFK (5µg) and pMCFR65 (5µg) PMCluc12pax 
(0.5µg) 
R-luc 
(0.5µg) 
Activity luc Activity R-luc Quotient 
1 (-) - + + 155 1007 0.15 
2 (-) - + + 140 693 0.2 
Average - + + 147.5 850 0.175 
3 (-) + + + 980 20908 0.047 
4 (-) + + + 689 13713 0.05 
5 (-) + + + 157 1347 0.12 
6 (-) + + + 177 63796 0.00 
7 (-) + + + 145 2656 0.06 
8 (-) + + + 195 7279 0.026 
9 (-) + + + 1052 5036 0.209 
Average + + + 485 16390.7 0.029 
10 (+) + + + 892 97545 0.009 
11 (+) + + + 18658 75574 0.247 
12 (+) + + + 4960 20851 0.239 
13 (+) + + + 10262 18167 0.57 
14 (+) + + + 338 1931 0.175 
15 (+) + + + 159 1047 0.152 
16 (+) + + + 11909 90900 0.131 
17 (+) + + + 351 3342 0.11 
Average + + + 5941 38670 0.154 
Induction by the presence of Rapalog. 5.3 fold 
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The results shown in tables 5 and 6 show that the addition of Rapalog hardly 
enhances luciferase transcription of pMCluc12Pax. Therefore we tried to 
electroporate the DNA into the hindbrain instead of the midbrain. Table 7 shows the 
results. 
 
Tab. 7: Induction by Rapalog.  “-“ indicates that the same amount of Bluescript KS- was electroporated. “(-)”indicates that no 
Rapalog was added. The DNA was electroporated into the hindbrain. 
 
No improvement was observed. Tables 4 - 7 show that the Rapalog inducible two 
hybrid system works, but the induction by addition of Rapalog was very low.  
 
 
To test, how the effect of cycloheximide is, we electroporated the same constructs 
into the chicken embryo, but added 1µg/ml cycloheximide to some samples at the 
same time Rapalog was added. Table 8 gives an overview of this. Cycloheximide 
inhibits protein synthesis and is therefore useful to distinguish primary and secondary 
target genes. But, as it inhibits protein synthesis, it is also toxic for the cells. Cells 
Embryo 
Rapalog 
(+/-) 
pMCPDFK (5µg) and pMCFR65 (5µg) PMCluc12pax 
(0.5µg) 
R-luc 
(0.5µg) 
Activity luc Activity R-luc Quotient 
1 (-) - + + 180 2662 0.07 
2 (-) - + + 169 5360 0.03 
3 (-) - + + 196 6818 0.03 
Average - + + 182 4947 0.04 
4 (-) + + + 1900 163384 0.011 
5 (-) + + + 253 245587 0.0 
6 (-) + + + 213 197656 0.0 
7 (-) + + + 2116 415043 0.0 
8 (-) + + + 1089 144091 0.008 
9 (-) + + + 240 41226 0.006 
Average + + + 968.5 160233 0.006 
10 (+) + + + 4297 85081 0.05 
11 (+) + + + 17826 90704 0.2 
12 (+) + + + 35482 247005 0.144 
13 (+) + + + 26698 856945 0.03 
14 (+) + + + 7236 515389 0.014 
15 (+) + + + 9023 2732951 0.004 
16 (+) + + + 279 61804 0.005 
Average + + + 14405.9 655697 0.022 
Induction by the presence of Rapalog. 3.6 fold 
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whose protein synthesis is blocked can react unexpectedly. So we had to test, 
whether rapalog induced luciferase expression is altered by the treatment with 
cycloheximide. 
Embryo FR16 
(5µg) 
PDFK 
(5µg) 
pMCRluc 
(0.5µg) 
pMCluc12Pax 
(0.5µg) 
CHX Rapalog Activity 
luc 
Activity   
R-luc 
Quotient 
1 - - - - - - 234 1096 0,214 
2 - - + - - - 398 536892 0,001 
3 - - + + - - 765 467932 0,002 
4 + - + + - - 459 872182 0,001 
5 - + + + - - 678 349872 0,002 
6 + + + + - - 8723 398129 0,022 
7 + + + + - - 11001 783912 0,014 
8 + + + + - - 10234 398123 0,026 
9 + + + + - - 9823 298123 0,033 
10 + + + + + - 9578 98123 0,098 
11 + + + + + - 7652 106287 0,072 
12 + + + + + - 9099 129832 0,07 
13 + + + + + - 10761 209123 0,051 
14 + + + + + - 9871 92340 0,107 
15 + + + + + + 32871 89923 0,366 
16 + + + + + + 12765 87712 0,146 
17 + + + + + + 10238 99023 0,103 
18 + + + + + + 49199 99712 0,493 
19 + + + + + + 20712 101234 0,205 
20 + + + + + + 9982 90543 0,11 
21 + + + + - + 5002 651982 0,008 
22 + + + + - + 53892 762109 0,071 
23 + + + + - + 72982 499823 0,146 
24 + + + + - + 65839 599234 0,11 
25 + + + + - + 48729 676234 0,072 
Average without rapalog and without CHX 0,024 
Average with rapalog and without CHX 0,081 
Average without rapalog and with CHX 0,08 
Average with rapalog and with CHX 0,237 
Rluc without CHX 563074,3 
Rluc with CHX 109441,1 
%Decrease by addition of CHX 80,5 
Ratio rapalog -/+ without CHX 3,37 
Ratio rapalog -/+ with CHX 2,96 
%Decrease of rapalog induction by addition of CHX 12,2 
Tab. 8.:  Functionality of the rapalog inducible two hybrid system and the influence of cycloheximide (CHX). 
 
 
Addition of cycloheximide (CHX) had no major influence on Firefly luciferase 
expression. However addition of cycloheximide led to a decrease of Renilla luciferase 
expression to almost 19 % of the original activity. This shows that many cells 
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probably die after addition of cycloheximide. Nevertheless, Table 8 shows that the 
proposed two hybrid system is functional in chick embryos for inducible transcription 
control, but the efficiency of induction is very low compared to cell culture 
experiments. Therefore further experiments were done with plasmid pMCPDVP16, 
that carries the non inducible constitutively expressed construct PDVP16 or with the 
constitutively expressed pMCFgfFK. 
 
3.3. Target genes of Pax2 and Fgf8-signalling 
 
3.3.1. Pax5 is supposed to be a target gene of Pax2 
 
To identify putative Pax2 target genes 20 ng of plasmid pMCPDVP16 were 
electroporated into the neural tube of chick-embryos in the 10-12 somite stage. The 
eggs were incubated for another day at 37° C and then the embryo was cut out of the 
egg and fixed. In situ hybridisation assays with Pax5-RNA were done. Figures 7 and 
8 show two pictures of embryos probed with Pax5-RNA. 
 
Fig. 7: Chick-embryo probed with Pax5. Blue colour: positive “in-situ” hybridization of the probe. 
Electroporation was performed with anodes on the left side (see arrow), so that pMCPDVP16 was 
introduced into the left cells of the neural tube. Both sides of the neural tubes are marked in the picture 
with red colour. 
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Fig. 8: Chick-embryo probed with Pax5. Blue colour: positive “in-situ” 
hybridization of the probe. Electroporation was performed with anodes on 
the left side (see red arrow), so that pMCPDVP16 was introduce into the 
left cells of the neural tube. Both sides of the neural tubes are marked in 
the picture with red colour. 
. 
 
Figures 7 and 8 show that hybridisation is only visible at the left half of the neural 
tube, i.e. the half where pMCPDVP16 was introduced by electroporation. This means 
that the presence of pMCPDVP16 alone led to the production of Pax5 mRNA. This 
suggests that the PDVP16 hybrid protein induces Pax5-transcription. Since the 
paired domain of PDVP16 and the paired domain of Pax2 are highly similar, it is 
likely that Pax2 acts as a transcriptional enhancer of Pax5.  
In addition to the hybridisation with the Pax5-probe, morphological changes were 
also visible at the side of the neural tube where pMCPDVP16 was introduced. In 
Figure 7 we can observe that the third brain vesicle completely disappeared at the 
electroporated side. Transcriptional activation of Pax2 target genes apparently 
abolishes formation of the metencephalic vesicle. This morphologic change can not 
be observed in Figure 8, but this could be because the right half of the neural tube 
got lost during embryo dissection. 
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3.3.2. Pea3 and Spy1 transcription is supposed to be induced by Fgf8 
 
To look for genes induced by Fgf8 we constructed the inducible Fgf-receptor. 
pMCFgfFK contains the Rapalog / Rapamycin binding FK domain fused to an Fgf-
receptor protein that lacks the signal peptide. This protein is expressed by the strong 
CMV promoter. Like Rapalog binds to one FK and one FR domain, Rapamycin binds 
to two FK domains and is therefore able to dimerise the FgfR1FK hybrid protein. 
Dimerisation of the Fgf8-receptor results in activation of a cascade and transcription 
of some genes. In nature binding of Fgf8 to the Fgf-receptor results in dimerisation of 
the Fgf-receptor and activation of the downstream-cascade. In our system we do not 
need Fgf8. Addition of an artificial derivate of Rapamycin should have the same 
effect. The advantage of this system is, that we can exclude disturbing effects by the 
addition of Fgf8 to the embryo. The non-functional FgfFK is expressed in high 
amounts only in the electroporated half. Then Rapamycin derivate was added and 
cells were fixed almost 6 hours after addition. There should be no time for any 
disturbing effect.  
In our experiment we first electroporated chick embryos in the 10-12 somite stage 
with 20 ng of plasmid pMCFgfFK. The electroporated embryos were incubated in 
their eggs (closed with Parafilm) at 37 °C for one day. Then they were cut out of the 
egg and transferred to a well (24 well plate) filled with DME medium. After one hour 
Rapamycin was added and six hours later the embryo was fixed (with Pfa (4%) and 
Methanol, see methods) and “in-situ” hybridizations were performed with Pea3 and 
Spy1 probes. Figures 9, 10 and 11 show the results. 
The embryo probed with Pea3 show a similar morphological phenotype to the Pax5 
probed embryo electroporated with pMCPDVP16. The pMCFgfFK electroporated 
side showed no brain vesicles. It can also be observed that the probe (Pea3) 
hybridised stronger on the electroporated side than on the not electroporated side. 
This suggests  that Fgf-receptor activation induced Pea3 expression. However, the 
Pea3 probe also hybridised at the unelectroporated right part of the neural tube. This 
indicates that Pea3 transcriptional activation by the Fgf-receptor might be less 
significant than that of Pax5 by Pax2.  
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Fig. 9: Chick embryo probed with Pea3. pMCFgfFK was electroporated into the left side of the 
neural tube. Pea3-probe gives blue staining. Both sides of the neural tubes are marked in the 
picture with red colour. 
 
 
 
Fig. 10: Chick embryo probed with Spy1. pMCFgfFK was electroporated 
into the left side of the neural tube: Spy1-probe gives blue staining. Right 
and left margins of the neural tube and brain vesicles are marked in the 
picture with red colour. Arrows indicate that both sides of the neural tube 
and brain vesicles give blue staining. 
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pMCFgfFK electroporated embryos probed with Spy1 did not show any changes to 
unelectroporated embryos. Figure 10 shows hybridisation of Spy1 at both sides of 
the neural tube. Hybridisation is higher at the telencephalic region. On the other hand 
we could see hybridisation at more posterior regions of the embryo. This could be 
due to a mistake during injection and electroporation, where pMCFgfFK was also 
electroporated in a posterior region. It could be observed that Spy1 hybridises at this 
region, which suggests that Spy1 expression is activated by Fgf-signalling, but 
misexpression of the Fgf-receptor did not change the expression pattern of some 
putative target genes in the brain region at these embryonic stages.  
 
 
Fig. 11: Chick embryo probed with Spy1. pMCFgfFK 
was electroporated into the left side of the neural 
tube. Spy1-probe gives blue staining. Right and left 
margins of the neural tube and brain vesicles are 
marked in the picture with red colour. Arrows indicate 
that both sides of the neural tube give blue staining. 
 
In Figure 11 we can observe that the Spy1 probe hybridised at both sides of the 
neural tube, indicating that expression and activation of the artificial Fgf receptor had 
no influence on the expression of Spy1 on the brain region. However this embryo 
lacks posterior parts so that the effect of Fgf-receptor activation at more posterior 
regions (showed in Fig. 10) could neither be verified nor falsified. 
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4. Discussion 
 
 
 
4.1. The Rapalog / Rapamycin inducible system 
 
Overexpression of regulatory proteins may disturb the whole gene-expression pattern 
in a cell and thus be lethal. The Rapalog / Rapamycin inducible system provides a 
system in which the overexpressed regulatory proteins remain inactive until the 
addition of Rapalog or Rapamaycin. We tested this system with two different 
proteins. 
 
1. The FgfFK system: FgfFK is a fusion protein of the Fgf-receptor and the 
Rapamycin binding FK domain. This fusion protein is expressed by a very 
strong promoter (CMV-promoter) and therefore produced in high amounts. As 
the Fgf-Receptor is only active in its dimerised form, the FgfFK protein 
remains inactive until an artificial derivate of Rapamycin is added. Each 
molecule binds two FK domains and dimerizes FgfFK. The dimerized FgfFK is 
active and activates a cascade that results in transcriptional activation of Fgf 
target genes. In our case we tested this system in chicken embryos and saw 
that the artificially activated FgfFK system was functional as it turned on 
transcription of the Pea3 gene (Fig. 9) 
 
2. The PDFK-FR65 system: This system consists of two plasmids. One encodes 
the DNA binding “Paired domain” of the transcriptional activator Pax2 fused to 
three Rapamycin / Rapalog binding FK domains. The other plasmid encodes a 
fusion protein of the Rapalog binding FR domain fused to the transactivation 
domain of the p65 gene. Both fusion proteins are expressed by the strong viral 
CMV promoter and are therefore produced in high amounts. However, they 
are inactive until Rapalog is added. Each Rapalog molecule binds one FK and 
one FR domain and brings them together. As there are three FK domains 
fused to the “Paired domain” three p65 transactivation domains are fused to 
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each “Paired domain”. As a result a very strong transcrpitional activator is 
made that should activate transcription of all ORFs downstream of the “Paired 
domain” binding element.  
In our experiments we could show in chick embryos electroporated with 
pMCPDFK (containing the DNA binding domain fused to FK), pMCFR65 
(containing the transactivation domain fused to FR) and pMCluc12Pax 
(containing the “Paired domain” binding sequence upstream of the Firefly 
luciferase gene) that luciferase activity can be induced by Rapalog addition. 
Anyway this induction was not strong (Tab. 2). It was much lower than the 
luciferase activity of chick embryos electroporated with pMCPDVP16, where 
the whole transcriptional activator is encoded in one plasmid (Tab. 1). This 
suggests that one possible reason for the low Rapalog induced activation 
could be the low amount of plasmids that entered the cells. At least three 
plasmids (pMCPDFK, pMCFR65 and PMCluc12Pax) must be in the same cell 
to get Rapalog inducible transcription of the luciferase gene. May be that only 
a few cells got all three plasmids in the right amounts and therefore the 
luciferase activity was not as high as expected. In contrast, if pMCPDVP16 is 
used, only two plasmids must enter the same cell to give a functional system. 
This could explain the higher luciferase activity when pMCPDVP16 is used.  
One possibility to avoid this problem would be the construction of one plasmid 
containing the three genes (PDFK under CMV control, FR65 under CMV 
control and luc under control of a minimal promoter downstream of a “Paired 
domain” binding element). 
       
 
4.2. Effects of Fgf-receptor activation and PDVP16 
expression 
 
 
4.2.1. Effects of Fgf-receptor activation 
 
With the Rapamycin inducible Fgf-receptor (FgfFK) we could see several effects in 
10-12 somite chick embryos. On the one hand we could show by “in situ” 
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hybridisation with Pea3 RNA probes that the Pea3 gene is activated by the Fgf 
receptor (Fig. 9). On the other hand we observed that the metencephalic brain 
vesicle disappeared when Fgf-receptor was activated. As we did not look at other 
genes that are controlled by Fgf receptor activation, we cannot assure that this 
phenotype is due to Pea3 overexpression or due to overexpression of another Fgf-
controlled gene we did not look at [59]. We didn’t see any alteration in Spy1 
expression pattern by Fgf-receptor activation (Fig. 10 and 11). 
 
4.2.2. Effects of the “Paired domain” binding transcriptional activator PDVP16 
on the gene expression pattern in 10-12 somite chick embryos. 
 
Embryos electroporated with pMCPDVP16 showed high amounts of Pax5 mRNA at 
the electroporated region. It is very likely that PDVP16 activates Pax5 transcription 
(Fig. 7). On the other hand we also saw that the metencephalic brain vesicle 
disappeared at the electroporated region. It remains unclear whether this 
disappearance is driven by Pax5 expression or not, because it is very probable that 
PDVP16 changes the expression pattern of many different genes [60]. 
PDVP16 contains the same DNA binding domain as Pax2. As PDVP16 induces Pax5 
transcription it is very likely that Pax2 has the same effect. To verify this, further 
experiments, in which the native Pax2 is misexpressed, should be done. 
PDVP16 as well as the dimerized Fgf-receptor cause disappearance of the 
metencephalic brain vesicle at the side where these two genes were misexpressed. 
Embryos electroporated with Bluescript control DNA did not show this effect. This 
indicates that it is not an artefact, but a consequence of misexpression of PDVP16 
and Fgf-receptor activation. The exact mechanism, that causes this effect, remains to 
be investigated. 
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6. Anhang 
6.1. Abstract 
 
Several molecular mechanisms control the patterning and differentiation 
of the neural tube along the anteroposterior axis. Early transplantation 
experiments in chicken showed that there is an autonomic organizing 
centre in the mid/hindbrain boundary that is highly interesting for the 
investigation of the mechanisms of cell differentiation and the genes that 
induce it. In order to identify unknown target genes of known regulatory 
proteins, we developed a system which is able to activate misexpression 
by Rapamycin mediated dimerization of the proteins of interest. The 
experiments were performed on chick embryos and the DNA was 
introduced into the desired region by electroporation. This system 
allowed us to turn on misexpression in a specific region and 
developmental stage. In order to determine the direct target genes we 
used the translation inhibitor Cycloheximide (CHX) so that no further 
translation could occur after the putative primary target genes were 
activated and the mRNA synthesized. We tested this system with 
different proteins. The FgfFK is a fusion protein of the Fgf-receptor and 
the Rapamycin binding FK domain which is activated by induced 
dimerisation. The PDFK-FR65 System consists of two plasmids, one 
encoding the DNA binding “Paired domain” of the transcriptional activator 
Pax2 fused to three Rapamycin/Rapalog binding FK domains, the other 
one encoding a fusion protein of the Rapalog binding FR domain fused 
to the transactivation domain of the p65 gene. Finally the pMCPDVP16 
system, were the whole transcriptional activator is encoded in one 
plasmid. With the Rapamycin inducible Fgf-receptor (FgfFK) we could 
show by “in situ” hybridisation with Pea3 RNA probes that the Pea3 gene 
is activated by the Fgf-receptor. We didn’t see any alteration in Spy1 
expression pattern. Embryos electroporated with pMCPDVP16 showed 
high amounts of Pax5 mRNA at the electroporated region. It is very likely 
that PDVP16 activates Pax5 transcription. PDVP16 contains the same 
DNA binding domain as Pax2, so it is also very likely that Pax2 has the 
same effect. PDVP16 as well as the dimerized Fgf-receptor cause 
disappearance of the metencephalic brain vesicle at the side where 
these two genes were misexpressed. Embryos electroporated with 
Bluescript control DNA did not show this effect. This indicates that it is 
not an artefact, but a consequence of misexpression of PDVP16 and 
Fgf-receptor activation. The exact mechanism, that causes this effect, 
remains to be investigated. 
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6.2. Zusammenfassung 
 
 
Verschiedene molekulare Mechanismen steuern die Differenzierung und 
Ausbildung von Zellmustern im Neuralrohr entlang der anteroposterioren 
Achse. Transplantationsstudien im Huhn zeigten, dass ein autonomes 
Organisationszentrum an der Grenze zwischen Met- und 
Mesencephalon existiert, welches interessant für die Erforschung der 
Mechanismen der Zelldifferenzierung und der involvierten Gene ist. Um 
unbekannte Targetgene von bekannten regulatorischen Faktoren zu 
identifizieren, entwickelten wir ein System, bei dem die Missexpression 
eines zu untersuchenden Proteins durch Dimerisierung mittels 
Rapamycin induziert werden konnte. Die Experimente wurden an 
Hühnerembryos durchgeführt und die DNA mittels Elektroporation in die 
gewünschte Region eingeschleust. Mittels dieses Systems waren wir in 
der Lage die Missexpression an einem spezifischen Ort und im 
gewünschten Entwicklungsstadium zu induzieren. Um direkte 
Targetgene zu identifizieren, wurde der Translationsinhibitor 
Cycloheximid (CHX) verwendet, wodurch die Translation der mRNA der 
Targetgene unterbunden wurde. Dieses System wurde mit 
unterschiedlichen Expressionskonstrukten getestet. FgfFK ist ein 
Fusionsprotein aus dem Fgf-Rezeptor und der Rapamycin bindenden 
FK-Domäne, welches durch induzierbare Dimerisierung aktiviert werden 
konnte. Das PDFK-FR65-System wiederum bestand aus zwei 
Plasmiden. Eines kodierte für die DNA-bindende „Paired domain“-Region 
des Transkriptionsfaktors Pax2, fusioniert mit der Rapamycin/Rapalog 
bindenden FK-Domäne, das andere für die Rapalog bindende FR-
Domäne, fusioniert mit dem transaktivierenden Bereich des p65-Gens. 
Das pMCPDVP16 Expressionskonstrukt enthielt den gesamten 
Transkriptionsaktivator auf einem Plasmid. Mit dem induzierbaren FgfFK-
System konnten wir, mittels In-situ-Hybridisierung, nachweisen, dass der 
Fgf-Rezeptor die Expression des Gens Pea3 aktiviert. Keine 
Veränderung konnte im Expressionsmuster von Spy1 beobachtet 
werden. Mit pMCPDVP16 elektroporierte Embryos zeigten in dieser 
Region hohe Mengen an Pax5 mRNA. Da PDVP16 dieselbe DNA-
bindende Domäne enthält wie Pax2, ist es wahrscheinlich, dass Pax5 ein 
direktes Targetgen von Pax2 ist. Sowohl bei mit FgfFK, als auch bei den 
mit PDVP16 elektroporierten Embryos, verschwand auf der Seite, auf 
der die Missexpression stattfand, das metencephalische Vesikel. Bei 
Elektroporation mit Bluescript-Kontroll-DNA wurde dies nicht beobachtet, 
was darauf hinweist, dass es sich nicht um ein Artefakt handelt. Der 
Mechanismus, der dies verursacht, bleibt zu untersuchen. 
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